Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uhi Toh

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Surgery Today|October 24, 2013
Usefulness of endoscopic breast-conserving surgery for breast cancerHiroki Takahashi, Teruhiko Fujii, Shino Nakagawa, et al.
Histopathology|September 26, 2019
Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expressionMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
International Journal of Clinical Oncology|December 21, 2002
Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancerUhi Toh, Tomoya Sudo, Kouichiro Kido, et al.
World Journal of Surgery|April 26, 2003
Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomyHiromasa Fujita, Susumu Sueyoshi, Toshiaki Tanaka, et al.
Cancer Science|November 2, 2016
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancerMina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
World Journal of Surgical Oncology|November 15, 2024
The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective studyRie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, et al.
Hellenic Journal of Nuclear Medicine|March 19, 2018
Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancerHayato Kaida, Koichi Azuma, Uhi Toh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer]Uhi Toh, Teruhiko Fujii, Kousuke Tayama, et al.
Japanese Journal of Clinical Oncology|July 18, 2014
Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodesMari S Oba, Shigeru Imoto, Uhi Toh, et al.
Oncology Reports|July 14, 2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cellsTeruhiko Fujii, Anna M Nakamura, Goro Yokoyama, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Surgery Today|October 24, 2013
Usefulness of endoscopic breast-conserving surgery for breast cancerHiroki Takahashi, Teruhiko Fujii, Shino Nakagawa, et al.
Histopathology|September 26, 2019
Diverse histomorphology of HER2-positive breast carcinomas based on differential ER expressionMomoko Akashi, Rin Yamaguchi, Hironori Kusano, et al.
International Journal of Clinical Oncology|December 21, 2002
Locoregional adoptive immunotherapy resulted in regression in distant metastases of a recurrent esophageal cancerUhi Toh, Tomoya Sudo, Kouichiro Kido, et al.
World Journal of Surgery|April 26, 2003
Optimal lymphadenectomy for squamous cell carcinoma in the thoracic esophagus: comparing the short- and long-term outcome among the four types of lymphadenectomyHiromasa Fujita, Susumu Sueyoshi, Toshiaki Tanaka, et al.
Cancer Science|November 2, 2016
Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancerMina Okabe, Uhi Toh, Nobutaka Iwakuma, et al.
World Journal of Surgical Oncology|November 15, 2024
The effective duration of systemic therapy and the neutrophil-to-lymphocyte ratio predict the surgical advantage of primary tumor resection in patients with de novo stage IV breast cancer: a retrospective studyRie Sugihara, Hidetaka Watanabe, Shuntaro Matsushima, et al.
Hellenic Journal of Nuclear Medicine|March 19, 2018
Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancerHayato Kaida, Koichi Azuma, Uhi Toh, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 2004
[The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer]Uhi Toh, Teruhiko Fujii, Kousuke Tayama, et al.
Japanese Journal of Clinical Oncology|July 18, 2014
Observational study of axilla treatment for breast cancer patients with 1-3 positive micrometastases or macrometastases in sentinel lymph nodesMari S Oba, Shigeru Imoto, Uhi Toh, et al.
Oncology Reports|July 14, 2005
Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cellsTeruhiko Fujii, Anna M Nakamura, Goro Yokoyama, et al.
Pageof 7